Dianthus Therapeutics Banner

SEC Filing Details

Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q2 2026 Financial Results

Document Details

Form
Filing Date
Aug 11, 2026
Document Date
Aug 10, 2026
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Dianthus Therapeutics
Issuer
DIANTHUS THERAPEUTICS, INC. /DE/
Filer
Read Simon